A SUBCUTANEOUSLY ADMINISTERED INVESTIGATIONAL RNAI THERAPEUTIC (ALN-CC5) TARGETING COMPLEMENT C5 FOR TREATMENT OF PNH AND COMPLEMENT-MEDIATED DISEASES: INTERIM PHASE 1 STUDY RESULTS
EHA Library, Anita Hill, 135230
A FUSION PROTEIN OF INTERLEUKIN-4 AND INTERLEUKIN-10 PROTECTS AGAINST BLOOD-INDUCED CARTILAGE DAMAGE IN VITRO AND IN VIVO
EHA Library, Lize van Vulpen, 135225
CHILDREN WITH SICKLE CELL ANEMIA ON CHRONIC TRANSFUSION FOR ABNORMAL TRANSCRANIAL DOPPLER VELOCITIES. PATIENT/SIBLING COMPARISON OF COGNITIVE PERFORMANCES AND ASSOCIATION WITH NEUROIMAGING DATA
EHA Library, Francoise Bernaudin, 135220
GLUCOSE AND LIPID METABOLISM ABNORMALITIES DURING NILOTINIB TREATMENT AND COMPARISON WITH IMATINIB AND DASATINIB THERAPY ? RESULTS FROM ENIGMA 2 STUDY
EHA Library, Zdenek Racil, 135189
BONE MARROW FAILURE IN PAROXYSMAL NOCTURNAL HEMOGLOBULINURIA IS ASSOCIATED WITH EXPANSION OF ANTIGEN-SELECTED T CELLS: HIGH-THROUGHPUT EVIDENCE
EHA Library, Evangelia Stalika, 135229
RESPONSIVENESS OF HEMOPHILIA B-CAUSING NONSENSE MUTATIONS TO RIBOSOME READTHROUGH-INDUCING DRUGS STRICTLY DEPENDS ON THE NUCLEOTIDE AND PROTEIN CONTEXT
EHA Library, Alessio Branchini, 135224
DOPPLER ULTRASOUND RELIABLY IDENTIFIES SICKLE CELL DISEASE ADULT PATIENTS WITH INTRACRANIAL VASCULOPATHY
EHA Library, Pablo Bartolucci, 135219
FLT3-D835Y AND NPM1C ONCOGENES COOPERATE TO INDUCE AN AGGRESSIVE MPN IN MICE.
EHA Library, Alina Rudorf, 135214
IMPACT OF THE MOLECULAR PROFILE ON THE RISK OF ACUTE MYELOID TRANSFORMATION IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA
EHA Library, Alberto Alvarez-Larrán, 135209
A NEW MULTIPLE MYELOMA CLASSIFICATION SYSTEM THAT CORRELATES TO DISEASE STAGE AND PROGNOSIS - INDICATION OF REVERSIBLE PHENOTYPIC PLASTICITY AS A HALLMARK
EHA Library, Hans Erik Johnsen, 135204
INTEGRATIVE GENOMICS IDENTIFIES THE MOLECULAR BASIS OF RESISTANCE TO AZACITIDINE THERAPY IN MYELODYSPLASTIC SYNDROMES
EHA Library, Ashwin Unnikrishnan, 135199
OVERALL SURVIVAL OUTCOMES IN PATIENTS WITH MANTLE-CELL LYMPHOMA (MCL) TREATED WITH IBRUTINIB IN A POOLED ANALYSIS OF 370 PATIENTS FROM 3 INTERNATIONAL OPEN-LABEL STUDIES
EHA Library, Simon Rule, 135194
QUANTITATIVE MRD IS PROGNOSTIC FOR PROGRESSION-FREE & OVERALL SURVIVAL IN ELDERLY PATIENTS RECEIVING CHLORAMBUCIL ALONE OR WITH OBINUTUZUMAB/RITUXIMAB: A PROSPECTIVE ANALYSIS OF THE GCLLSG CLL11 STUDY
EHA Library, Matthias Ritgen, 135184
DYSREGULATED MIR34A/DIACYLGLYCEROL KINASE ? INTERACTION ENHANCES T-CELL ACTIVATION IN ACQUIRED APLASTIC ANEMIA
EHA Library, Yuanxin Sun, 135228
FIRST RESULTS FROM A DOSE-ESCALATING STUDY WITH AAV5 VECTOR CONTAINING WILD TYPE HUMAN FACTOR IX GENE THERAPY IN PATIENTS WITH SEVERE OR MODERATELY-SEVERE HAEMOPHILIA B
EHA Library, Frank Leebeek, 135223
RESULTS OF TRANSCRANIAL DOPPLER ULTRASOUND SCREENING FROM THE POST-STOP STUDY
EHA Library, Julie Kanter, 135218
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL
EHA Library, Paolo Sportoletti, 135213
LONG-TERM OUTCOMES OF RUXOLITINIB (RUX) THERAPY IN PATIENTS (PTS) WITH MYELOFIBROSIS (MF): 5-YEAR FINAL EFFICACY AND SAFETY ANALYSIS FROM COMFORT-I
EHA Library, Srdan Verstovsek, 135208
A TARGETED SEQUENCING APPROACH IN MULTIPLE MYELOMA REVEALS A COMPLEX LANDSCAPE OF GENOMIC LESIONS THAT HAS IMPLICATIONS FOR PROGNOSIS
EHA Library, Niccolò Bolli, 135203
DYNAMICS OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES.
EHA Library, Hideki Makishima, 135198
15-YEAR FOLLOW-UP OF THE NORDIC MCL2-TRIAL: DESPITE LONG-TERM RESPONSES LATE RELAPSES STILL OCCUR.
EHA Library, Christian Winther Eskelund, 135193
EFFICACY AND SAFETY OF IMATINIB GENERICS; A REPORT FROM POLISH (PALG) IMATINIB GENERICS REGISTRY
EHA Library, Tomasz Sacha, 135188
PRELIMINARY SAFETY DATA FROM THE PHASE 3B GREEN STUDY OF OBINUTUZUMAB (G) ALONE OR COMBINED WITH CHEMOTHERAPY FOR PREVIOUSLY UNTREATED OR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
EHA Library, Véronique Leblond, 135183
Patents and diagnostic testing: another marriage on the rocks or a(n) (un)wanted relationship?
EHA Library, Sven Bostyn, 137078
Clones and subclones during ALL development
EHA Library, Jan Trka, 137083
Patenting in diagnostics: Damned if you do, damned if you don't
EHA Library, Eric Claassen, 137077
Oncogenetic heterogeneity of ALL cells
EHA Library, Stephen P. Hunger, 137082
Q&A and Panel Discussion
EHA Library, Faculty / Presenters, 141696
The meaning of circulating plasma cells in myeloma patients
EHA Library, Bruno Paiva, 137072
Symptoms and health-related quality of life issues considered important by patients with hematological malignancies: Patient perspective
EHA Library, Roger Else, 137067
Multiple myeloma: Spatial genomic heterogeneity between focal lesions and random bone marrow
EHA Library, Niels Weinhold, 137071
Challenges of assessing symptom burden in patients with hematological malignancies: Academic perspective
EHA Library, Tatyana Ionova, 137066
Hemostatic management of bleeding in obstetrics and gynecology
EHA Library, Claire Philipp, 136658
Genetic basis of rare inherited platelet disorders in the era of next-generation sequencing
EHA Library, Kathleen Freson, 136657
B-cell maturation pathways and migration
EHA Library, Alberto Orfao, 137070
Challenges of assessing symptoms for monitoring response to treatment in patients with ematological malignancies: Learning from best practice
EHA Library, Jonathan Kell, 137065
Blood outgrowth endothelial cells in understanding von Willebrand disease
EHA Library, Anna Randi, 136656
International Harmonization Group For Surveillance Of Late Effects Of Childhood Cancer
EHA Library, Leontien Kremer, 136655
The spectrum of late effects after cancer, lessons from pediatric oncology, and the value of international collaboration
EHA Library, Roderick Skinner, 136654
Deciphering genetic variation of early and late effects from childhood cancer therapies
EHA Library, Bruce Carleton, 136653
Antiplatelet therapy in acute and chronic ischemic heart disease
EHA Library, Freek Verheugt, 136652
Platelet reactivity testing: Is there a clinical relevance?
EHA Library, Jolanta Siller-Matula, 136651
Platelets and immunity
EHA Library, Harald Langer, 136650
Treatment of HLH in adults
EHA Library, Nancy Berliner, 136649
Malignancy associated HLH
EHA Library, Milen Minkov, 136648
HLH: Variations in etiology, pathophysiology and manifestations
EHA Library, Michael Jordan, 136647
The role of the blood film in diagnosing and managing red cell disorders
EHA Library, Barbara Bain, 136646
Clinical trials and potential targets of therapy in sickle cell disease
EHA Library, Bart Biemond, 136645
Anemia of chronic disease - New insights into its pathophysiology and therapy
EHA Library, Guenter Weiss, 136644
Mesenchymal Stem Cells As Treatment Of Chronic GvHD
EHA Library, Katarina Le Blanc, 136676
GVHD prophylaxis with PTCy
EHA Library, leo leonio, 136675
Recent advances in understanding the pathophysiology of GVHD
EHA Library, Ron Chakraverty, 136674
ADULTS AND CHILDREN (1-45 YEARS) WITH PH-NEGATIVE ALL HAVE ALMOST IDENTICAL OUTCOME IN RISK-STRATIFIED ANALYSIS OF NOPHO ALL2008
EHA Library, Nina Toft, 135343
INITIAL RESULTS FROM UKALL60+, A UK/HOVON COLLABORATIVE PHASE 2 STUDY IN ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA.
EHA Library, Nick MORLEY, 133159
RISK OF CEREBRAL VEIN THROMBOSIS (CVT) IN ADULT ALL PATIENTS IN FINLAND 1999-2012: SUGGESTION FOR A LEUKEMIA-RELATED PREDICTIVE SCORING MODEL
EHA Library, Saara Roininen, 133158
EFFICACY OF FRONT-LINE TREATMENT COMBINATIONS WITH PONATINIB VERSUS 1ST- AND 2ND-GENERATION TYROSINE KINASE INHIBITORS FOR PH+ ACUTE LYMPHOBLASTIC LEUKEMIA: A META-ANALYSIS AND META-REGRESSION
EHA Library, Elias Jabbour, 133157
THE COMBINATION OF BORTEZOMIB AND CHEMOTHERAPY IS AN EFFECTIVE TREATMENT TO RE-INDUCE REMISSION IN RELAPSED/REFRACTORY B-CELL PRECURSOR OR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Alice Bertaina, 133156
EFFICACY AND SAFETY OF INOTUZUMAB OZOGAMICIN IN OLDER PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA ENROLLED IN THE GLOBAL PHASE 3 RANDOMIZED CONTROLLED INO-VATE TRIAL
EHA Library, Elias Jabbour, 133155
TOLERANCE, COMPLIANCE AND EFFICACY OF L-ASPARAGINASE DURING INDUCTION PHASE IN ADULT PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF THE GRAALL-2005.
EHA Library, Marie Balsat, 133154
HIGH INCIDENCE OF PHILADELPHIA CHROMOSOME-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA (PH-LIKE ALL) IN OLDER ADULTS WITH B-ALL
EHA Library, Alexander Perl, 133153
BABOON ENVELOPE PSEUDOTYPED LENTIVIRAL VECTORS: A HIGHLY EFFICIENT NEW TOOL TO GENETICALLY MANIPULATE T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA INITIATING CELLS
EHA Library, Melania Tesio, 133152
MUTATIONAL STATUS OF NRAS, KRAS AND PTPN11 GENES IS ASSOCIATED WITH GENETIC/CYTOGENETIC FEATURES IN CHILDREN WITH B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Der-Cherng Liang, 133151
LOSS OF PIGH EXPRESSION FREQUENTLY RESULTS IN A GPI-NEGATIVE SUBCLONE LACKING CD52 MEMBRANE EXPRESSION, CONFERRING ALEMTUZUMAB RESISTANCE TO B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Inge Jedema, 133150
INTRINSIC AND SYNERGISTIC ACTIVITY OF ABT-199 AND OVERCOMING ABT-199 RESISTANCE BY THE CDK-INHIBITOR DINACICLIB IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Felix Seyfried, 133149
DEVELOPMENT OF A NOVEL FIRST-IN-CLASS ORAL INHIBITOR OF THE NOTCH PATHWAY.
EHA Library, Rajwinder Lehal, 133148
DETERMINING THE MUTATIONAL LANDSCAPE OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA REVEALS NR3C1 DELETIONS AND ACTIVATING MUTATIONS IN IL7R SIGNALING AS CAUSE OF STEROID RESISTANCE
EHA Library, Jules Meijerink, 133147
FUNCTIONAL RESTORATION OF MUTANT P53 AND CELL DEATH SENSITIZATION IN ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Salih demir, 133146
CHARACTERIZATION OF AN EX VIVO T-CELL CULTURE MODEL FOR THE STUDY OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Simon Bornschein, 133145
CLINICAL AND BIOLOGICAL LANDSCAPE OF DRIVER MUTATIONS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Hiroo Ueno, 133144
THE NUP214-ABL1 FUSION COOPERATES WITH TLX1 IN THE DEVELOPMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Marlies Vanden Bempt, 133143
RELAPSE OF ACUTE LYMPHOBLASTIC LEUKAEMIA IN OLDER/ELDERLY PATIENTS - A SWEDISH POPULATION-BASED STUDY
EHA Library, Emma Bergfelt Lennmyr, 133160
MICRORNA-155 AND MICRORNA-708 ARE OPPOSING MODULATORS OF HOXA9 ACTIVITY IN ACUTE MYELOID LEUKEMIA
EHA Library, Edith Schneider, 133161
A SOMATIC MUTATION OF GFI1B IDENTIFIED IN LEUKEMIA ALTERS CELL FATE VIA A SPI1 (PU.1) CENTERED GENETIC REGULATORY NETWORK
EHA Library, Eduardo Anguita, 133165
VENTX INDUCES EXPANSION OF PRIMITIVE ERYTHROID CELLS AND CONTRIBUTES TO THE DEVELOPMENT OF ACUTE MYELOID LEUKEMIA IN MICE
EHA Library, Eva Gentner, 133162
ABNORMAL INTRAGENIC TRANSCRIPTIONAL ACTIVATION IN MLL-AF9 AND KAT6A-CREBBP ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Anna Marneth, 133163
HHEX TRANSFORMS PROMYELOCYTES AND COOPERATES WITH FACTOR INDEPENDENCE TO CAUSE PROMYELOCYTIC LEUKEMIA IN MICE
EHA Library, Jacob T Jackson, 133164
CXCL12 ANTAGONISM BY THE L-RNA APTAMER OLAPTESED PEGOL IS EFFECTIVE AS A MOBILIZING AND THERAPEUTIC AGENT IN A MURINE CHRONIC LYMPHOCYTIC LEUKEMIA MODEL
EHA Library, Tanja Hartmann, 133184
IDENTIFICATION OF NOVEL B CELL RECEPTOR ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Elisa ten Hacken, 133183
GENOMIC CHARACTERIZATION OF HIGH-COUNT MBL INDIVIDUALS INDICATES THAT EARLYDETECTION OF DRIVER MUTATIONS AND SUBCLONAL EXPANSION ARE PREDICTORS OF ADVERSECLINICAL OUTCOME
EHA Library, Santiago Barrio, 133182
A PHASE I TRIAL OF A PHARMACODYNAMICALLY-CONCEIVED DECITABINE/THIOGUANINE COMBINATION IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES
EHA Library, Mark Frattini, 133181
RESULTS OF A PHASE 1B STUDY OF VENETOCLAX PLUS DECITABINE OR AZACITIDINE IN UNTREATED ACUTE MYELOID LEUKEMIA PATIENTS ≥65 YEARS INELIGIBLE FOR STANDARD INDUCTION THERAPY
EHA Library, Daniel A Pollyea, 133180
RESULTS OF A PHASE I STUDY OF GMI-1271, A NOVEL E-SELECTIN ANTAGONIST IN COMBINATION WITH INDUCTION CHEMOTHERAPY IN RELAPSED/REFRACTORY AML: A NOVEL, WELL-TOLERATED REGIMEN WITH A HIGH REMISSION RATE
EHA Library, Helen Thackray, 133179
CLINICAL RESPONSE IN RELAPSED/REFRACTORY AML PATIENTS CORRELATES WITH LEUKEMIC BLAST MOBILIZATION AND DIFFERENTIATION INDUCED BY BL-8040, A POTENT CXCR4 ANTAGONIST; RESULTS OF A PHASE IIA STUDY
EHA Library, Yaron Pereg, 133178
PHASE IB/II STUDY OF NIVOLUMAB IN COMBINATION WITH 5-AZACYTIDINE (AZA) IN PATIENTS (PTS) WITH RELAPSED ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Naval Daver, 133177
DIFFERENTIATION RESPONSE TO GILTERITINIB (ASP2215) IN RELAPSED/REFRACTORY FLT3 MUTATED ACUTE MYELOID LEUKEMIA PATIENTS IS ASSOCIATED WITH CO-MUTATIONS IN NPM1 AND DNMT3A
EHA Library, Jonathan Canaani, 133176
PHASE II STUDY OF CLADRIBINE AND LOW-DOSE ARAC ALTERNATING WITH DECITABINE IN OLDER PATIENTS WITH AML.
EHA Library, Tapan Kadia, 133175
SAFETY STUDY OF CRENOLANIB, A TYPE I FLT3 INHIBITOR, WITH CYTARABINE/DAUNORUBICIN OR CYTARABINE/IDARUBICIN INDUCTION AND HIGH-DOSE CYTARABINE CONSOLIDATION IN NEWLY DIAGNOSED FLT3+ AML
EHA Library, Eunice Wang, 133174
ORAL THROMBOPOIETIN RECEPTOR AGONIST ELTROMBOPAG TREATMENT DURING INDUCTION CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML): RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PHASE 2 STUDY
EHA Library, Noëlle Frey, 133173
AN EVALUATION OF THE TYROSINE KINASE INHIBITOR PACRITINIB IN PATIENTS WITH RELAPSED FLT3-MUTATED ACUTE MYELOID LEUKAEMIA (THE UK NCRI AML17 STUDY)
EHA Library, Steven , 133172
CHROMOTHRIPSIS: A NEW MECHANISM OF CANCER INITIATION AND PROGRESSION IN ADULT ACUTE MYELOID LEUKEMIA
EHA Library, Maria Chiara Fontana, 133171
TRIB2 REGULATES THE CELL CYCLE UNDER STRESS CONDITIONS IN A MURINE CELL MODEL OF LEUKEMIA.
EHA Library, Mara Salomè, 133170
TRIB2 TRANSFORMED GMP AS THE MYELOID LEUKEMIA INITIATING CELL
EHA Library, Krishna Yalla, 133169
CONDITIONAL DELETION OF THE HOXA CLUSTER IN MLL-AF9 IS INCOMPATIBLE WITH LEUKEMIA MAINTENANCE
EHA Library, Laura Kettyle, 133168
TRANSFORMING ACTIVITY OF THE NUP98-MLL FUSION IN A CONDITIONAL TRANSGENIC MOUSE MODEL
EHA Library, Angeliki Thanasopoulou, 133167
COMPARATIVE FUNCTIONAL ANALYSIS OF THE COMMON INTERACTORS OF 7 MLL FUSION PROTEINS
EHA Library, Anna Skucha, 133166
A PLATFORM FOR DETECTION OF FUSION GENES IN ALL FROM TARGET CAPTURE NEXT-GENERATION SEQUENCING OF DNA AND RNA.
EHA Library, Andrea Grioni, 133142
IDENTIFICATION OF CANDIDATE ONCOGENES AND CHROMOSOMAL BREAKPOINT SEQUENCING BY TARGETED LOCUS AMPLIFICATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Pieter Van Vlierberghe, 133141
HEDGEHOG PATHWAY ACTIVATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PREDICTS RESPONSE TO SMO AND GLI1 INHIBITORS
EHA Library, Jolien De Bie, 133140
MEF2C DYSREGULATION IS ASSOCIATED WITH CDKN1B DELETIONS AND PREDICTS POOR GLUCOCORTICOID RESPONSE IN PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Sara Colomer-Lahiguera, 133139
COMPARATIVE ANALYSIS OF GENE REGULATORY NETWORKS IN LYMPHOID LEUKEMIAS USING THE INTERACTIVE HEMAP RESOURCE
EHA Library, Juha Mehtonen, 133138

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings